Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Prospective Registry on Concomitant Use of Oral Anticoagulants and P2Y12 Inhibitors in Patients With Atrial Fibrillation or Heart Valve Prosthesis Undergoing Coronary Revascularisation.

NCT02635230 is registered in ClinicalTrials.gov with R&D Cardiologie as lead sponsor.

NCT NCT02635230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02635230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Prospective Registry on Concomitant Use of Oral Anticoagulants and P2Y12 Inhibitors in Patients With Atrial Fibrillation or Heart Valve Prosthesis Undergoing Coronary Revascularisation.
Lead sponsor
R&D Cardiologie
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2014
Completion date
January 31, 2022
Enrollment
2,200 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, atrial fibrillations, bleeding, coronary artery diseases, heart valve prostheses, myocardial infarction, stroke